Top news of the week: 07.04.2020.
#COVID19 #CoronaVirus #biotechnology #CoronaOutbreak #CoronaPandemic #biospace #lifesciences #pharmaceuticals
Companies And Industries
Biopharma Update on the Novel Coronavirus: April 1
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/W9sSk5Rno6
OpenBiopharma Update on the Novel Coronavirus: April 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 1, 2020.
Biotech Pioneer @Amgen Joins Hunt for #Coronavirus Drug https://t.co/FpuUr4i7tC https://t.co/KYsi2ShKZN
OpenBiotech Pioneer Amgen Joins Hunt for Coronavirus Drug
Big biotech company Amgen is joining the race to discover new drugs that can treat the novel coronavirus, the latest drugmaker redirecting resources toward the pandemic.
Biopharma equities start to recover as financial markets stabilize
After plunging dramatically at the beginning of the month, biopharmaceutical equities appear to be recovering some of the valuation they originally lost when the financial markets cratered. ...
Biopharma Update on the Novel Coronavirus: April 2
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/bTUUld7Q04
OpenBiopharma Update on the Novel Coronavirus: April 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.
Big biotech venture funds raise billions despite coronavirus fears https://t.co/2R2sJLYX6K via @statnews
OpenBig biotech venture funds raise billions despite coronavirus fears
These are difficult times. But two of the top biotech venture firms just raised a total of $2.6 billion to fund new startups.
.@GSK has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the #COVID19 #coronavirus https://t.co/jGrl1zm1cV
OpenGSK to collaborate with Chinese biotech on COVID-19 vaccine
GlaxoSmithKline has announced plans to collaborate China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus.
RT @adamfeuerstein: The biotech scorecard for the second quarter: 18 stock-moving events to watch (Coronavirus edition) https://t.co/cprT31z7WM
OpenThe biotech scorecard for the second quarter: 18 stock-moving events to watch
The coronavirus pandemic has fundamentally disrupted the biotech industry. But the second quarter still promises to be an extremely busy one.
Biotech Leaders Hit the Airwaves to Talk About Industry’s Efforts to Eradicate #COVID19 https://t.co/D1X6ZjKFcm https://t.co/JJuyd46ZCn
OpenBiotech Leaders Hit the Airwaves to Talk About Industry’s Efforts to Eradicate Covid-19
As the novel coronavirus continues to spread, scientists and researchers are working around the clock to identify diagnostics, therapeutics and vaccines to help protect individuals and ...